BIVI - BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.